Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Without the human safety data and a lack of FDA approval, sourcing peptides from an unregulated gray-market source introduces real risks of contamination, inaccurate dosing, and unknown ingredients
Knocking down disease: a progress report on siRNA therapeutics
Product specifications CAS Registry Number 885340-08-9344 Reported purity 98.5% Form Lyophilized laboratory research material Intended use Qualified in vitro laboratory research only
The primary outcome was the first occurrence of death from CV causes, nonfatal (including silent) MI, or nonfatal stroke
US$ 29.04
US$ 28.21
US$ 20.13
